Delivery Order SPE2DB20D1109-SPE2DB23FP51J
- Not listed
- This federal contract award, valued at $16,868.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a pharmaceutical product used to manage diabetes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award, valued at $8,486.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 4.5 mg/0.5 ml pens, a medication used to manage diabetes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC...
- This federal contract award, valued at $4,791.78, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a pharmaceutical product used for the treatment of diabetes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
- This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a prescription medication used to manage diabetes. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,482.24, is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a prescription medication used to treat type 2 diabetes. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves...
- This federal contract award, with a ceiling value of $10,812.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract involves the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. The IDC serves as the primary vehicle for...
- This federal contract award, valued at $2,734.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used for diabetes management. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the...
- This federal contract award, valued at $2,163.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5ml, a medication used to manage diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,081.92 delivery order is for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. The award was made under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award, valued at $2,543.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a medication used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP51JDelivery Order
This federal contract award, valued at $8,449.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. The contract is a delivery order under Cencora's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora to supply a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract award does not have a set-aside designation, indicating it was awarded through full and open competition. Cencora, Inc. also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 7/12/23 |